Events | Overall | Lean NAFLDa | Non-lean NAFLDb | |||
---|---|---|---|---|---|---|
n/N (%) | 1000 person years | n/N (%) | 1000 person years | n/N (%) | 1000 person years | |
Liver-related events | 11/405 (2.7%) | 3.72 | 4/148 (2.7%) | 3.08 | 7/257 (2.7%) | 4.23 |
Liver cancer | 9/418 (2.2%) | 2.96 | 6/155 (3.9%) | 4.49 | 3/263 (1.1%) | 1.76 |
Hepatic encephalopathy | 6/444 (1.4%) | 1.86 | 3/168 (1.8%) | 2.11 | 3/276 (1.1%) | 1.67 |
Esophagogastric varices | 7/432 (1.6%) | 2.22 | 3/163 (1.8%) | 2.16 | 4/269 (1.1%) | 2.26 |
Ascites | 9/441 (2.0%) | 2.80 | 4/167 (2.4%) | 2.82 | 5/274 (1.8%) | 2.78 |
Jaundice | 3/442 (0.7%) | 0.93 | 0/167 (0.0%) | 0.00 | 3/275 (1.1%) | 1.68 |
Cardiovascular events | 36/443 (8.1%) | 11.72 | 15/168 (8.9%) | 11.07 | 21/275 (7.6%) | 12.24 |
Type 2 diabetes mellitus | 34/298 (11.4%) | 15.43 | 12/128 (9.4%) | 10.95 | 22/170 (12.9%) | 19.88 |
Non-liver malignancies | 26/406 (6.4%) | 9.06 | 12/152 (7.9%) | 9.60 | 14/254 (5.5%) | 8.65 |